Table 1.
Characteristics of the subjects.
| Subjects | Control UT (n = 7) |
CRS (UT) (n = 15) |
Non-ECRS (NPs) (n = 24) |
ECRS (NPs) (n = 7) |
|---|---|---|---|---|
| Gender, male/female | 6/1 | 9/6 | 18/6 | 35/13 |
| Mean ± SEM, Age, years | 52.7 ± 19.4 | 49.3 ± 18.0 | 50.5 ± 15.6 | 54.7 ± 13.6 |
| Asthma, yes/no | 2/5 | 2/13 | 1/23 | 22/26 #,††† |
| AERD, yes/no | 0/7 | 0/15 | 0/24 | 3/45 |
| Mean ± SEM Serum total IgE (IU/mL) | 287.6 ± 324.4 | 743.2 ± 1390.1 | 322.7 ± 447.0 | 532.3 ± 1328.5 |
| Mean ± SEM, Eosinophils in peripheral blood (%) | 2.6 ± 1.3 | 3.9 ± 2.5 | 2.9 ± 1.4 | 6.8 ± 4.7 **,#,††† |
| Mean ± SEM, Total number of Eosinophils in peripheral blood | 138.2 ± 57.1 | 228.9 ± 163.5 | 156.8 ± 102.2 | 420.1 ± 331.6 **,#,†††† |
**; p < 0.01, vs. control uncinate tissue (UT), #; p < 0.05, vs. chronic rhinosinusitis (CRS) (UT), †††; p < 0.001, vs. Non-ECRS (nasal polyps (NPs)), ††††; p < 0.0001, vs. Non-ECRS (NPs).